These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1997797)

  • 21. T-level downstaging and complete pathologic response after preoperative long-term radiochemotherapy for locally advanced rectal cancer.
    Jonas J; Moroni E; Cavallaro A; Colasanti M; Sautter-Bihl ML; Frenzel H; Lohe B; Bähr R
    G Chir; 2007 Mar; 28(3):65-71. PubMed ID: 17419902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications.
    Ratto C; Ricci R; Valentini V; Castri F; Parello A; Gambacorta MA; Cellini N; Vecchio FM; Doglietto GB
    Ann Surg Oncol; 2007 Feb; 14(2):853-61. PubMed ID: 17103068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancers of the rectum in local advanced stage. Results in 29 treated cases in 25 years].
    Guillemin F; Vidrequin A; Chardot C
    Ann Chir; 1988; 42(4):255-61. PubMed ID: 3293520
    [No Abstract]   [Full Text] [Related]  

  • 24. Trends in the United States for the management of adenocarcinoma of the rectum.
    Mettlin C; Mittelman A; Natarajan N; Murphy GP; Schmitz RL; Smart CR
    Surg Gynecol Obstet; 1981 Nov; 153(5):701-6. PubMed ID: 7292270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
    Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
    Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal cancer: progress over the past two decades.
    Tulchinsky H; Rabau M
    Isr Med Assoc J; 2006 Oct; 8(10):711-2. PubMed ID: 17125121
    [No Abstract]   [Full Text] [Related]  

  • 27. Is it time for tailored treatment of rectal cancer? From prescribing by consensus to prescribing by numbers.
    Valentini V; Lambin P; Myerson RJ
    Radiother Oncol; 2012 Jan; 102(1):1-3. PubMed ID: 22178690
    [No Abstract]   [Full Text] [Related]  

  • 28. Penile metastasis from rectal carcinoma.
    Lo S; Crew J
    Singapore Med J; 2004 Jun; 45(6):299. PubMed ID: 15181528
    [No Abstract]   [Full Text] [Related]  

  • 29. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging.
    Kremser C; Judmaier W; Hein P; Griebel J; Lukas P; de Vries A
    Strahlenther Onkol; 2003 Sep; 179(9):641-9. PubMed ID: 14628131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative diagnosis of locally advanced rectal carcinoma after preoperative therapy].
    Barth C; Rau B; Hünerbein M; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1404-7. PubMed ID: 9931895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperthermia and hyperglycemia in the radiation and combined treatment of locally disseminated and recurrent rectal cancer].
    Knysh VI; Goldobenko GV; Barkanov AI; Ozhiganov EL; Timofeev IuM
    Med Radiol (Mosk); 1985 Sep; 30(9):32-7. PubMed ID: 2995756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Strategy and tactic in the treatment of local advanced rectal cancer].
    Angelescu N; Burcoş T; Jitea N; Voiculescu S; Stănilescu S; Florea I
    Chirurgia (Bucur); 2001; 96(1):15-22. PubMed ID: 12731163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 35. Complete clinical and pathological response to preoperative short course radiotherapy in T 2 rectal cancer.
    Selvasekar CR; Obeidat S; Simcock P; Khan AU
    Indian J Cancer; 2009; 46(4):350-1. PubMed ID: 19749473
    [No Abstract]   [Full Text] [Related]  

  • 36. Local excision and irradiation as primary treatment of rectal cancer.
    Tepper J; Herbst C; Bernard S
    N C Med J; 1988 Dec; 49(12):651-4. PubMed ID: 3065648
    [No Abstract]   [Full Text] [Related]  

  • 37. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
    Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
    Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma.
    Devries AF; Griebel J; Kremser C; Judmaier W; Gneiting T; Kreczy A; Ofner D; Pfeiffer KP; Brix G; Lukas P
    Cancer Res; 2001 Mar; 61(6):2513-6. PubMed ID: 11289123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined-modality neoadjuvant therapy for rectal cancer.
    O'Connell MJ
    J Clin Oncol; 2005 Aug; 23(24):5450-1. PubMed ID: 16009954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.